Graphic header for the Information Technology Laboratory home page. This includes the statment: ITL is supporting the information technology industry with measurements, standards, and research.
Healthcare graphic
copyright Photodisc

Conference Sponsors:

The Biotechnology Council (ASME, BMES, HIMSS, IEEE and SBE part of AIChE) and
the National Institute of Standards and Technology (NIST)

 

 

Economic Strategy for
Healthcare through Bio and Information Standards and Technologies
September 25, 2007

Agenda
 

Monday, September 24, 2007
6:00 – 8:00 PM
Welcome Reception– Holiday Inn - Conference Hotel
(Transportation available from Conference Hotel)
   
Tuesday, September 25, 2007
07:00 AM – 08:30 AM  Registration and Continental Breakfast
08:30 AM – 08:35 AM Welcome:  Biotechnology Council
08:35 AM – 08:40 AM

Introduction of Jerry Grossman – Honorary Chairman (Confirmed)
Senior Fellow and Director, Harvard/Kennedy School
Health Care Delivery Project and Chairman Emeritus of New England Medical Center (past member of the Boston Federal Reserve Board)
08:40 AM - 08:50 AM

Welcome:  Dr. James Turner, (confirmed)
NIST Deputy Director
08:50 AM – 09:00 AM

Introduction and Welcome: Connie Morella
(Confirmed) U.S. Ambassador to OECD
09:00 AM – 09:30 AM

Secretary Michael Leavitt-HHS (Invited)
09:30 AM – 01:00 AM

THE VALUE OF HEALTH CARE BIO AND INFORMATION TECHNOLOGIES
(with one break for coffee and networking)
  Keynote Address:
"Consumers: Shifting the Health Paradigm Peter Neupert" (confirmed), Corporate Vice President for Health Strategy, Microsoft Corporation (Introduction by Jerry Grossman)
10:00 AM - 10:10 AM Q & A
10:10 AM - 10:30 AM Morning Break
  Featured Presentations:
10:30 AM - 11:00 AM "The Role of Biotechnology and Bioinformatics in FDA's Critical Path Initiative" Janet Woodcock (Confirmed), Deputy Commission, FDA
11:00 AM - 11:30 AM

"Biotech 2007: A Global Transformation"; G. Steven Burrill (Confirmed) CEO, Burrill & Company (Introduction by Jerry Grossman)

11:30 AM - 12:00 PM "Approaches to Developing Government R&D Programs";
Greg Tassey (Confirmed) Senior Economist, NIST
12:00 PM - 12:40 PM

"The Potential of Biotechnology and Bioinformatics for Public Health" Anthony Arunel (Confirmed)SGEAU, OECD,

12:40 PM - 12:55 PM "Technology Innovation Program", Marc Stanley, (Confirmed), Acting Director Technology Innovation Program NIST
12:55 PM - 1:10 PM Q&A
1:00 PM – 02:00 PM

Lunch
2:00 PM - 5:30 PM

ASSESSING HEALTH CARE BIO AND INFORMATION TECHNOLOGY ECONOMICS
02:00 PM – 03:30 PM

Roundtable:  Marketplace Economics

Moderator:
Vijay Vaitheeswaran (Confirmed),
Correspondent  to The Economist

 

Participants:

Patrick Yang (Confirmed)
Executive VP, Genentech

Allan Korn, M.D., (Confirmed)
Senior VP and Chief Medical Officer, BC/BS

Mitchell Higashi, PhD., (Confirmed)
Senior Director, Health Economics & Outcomes Research,
GE Healthcare

G. Steven Burrill, (Confirmed), CEO, Burrill & Company

Greg Tassey, (Confirmed), Senior Economist, NIST

 
 

Q&A
03:30 PM – 03:45 PM

Afternoon Break
03:45 PM – 05:15 PM

Assessing Emerging Technology Benefits and Barriers

Panelists                                               

David Whitlinger, (Confirmed)
President and Board Chairman, Continua
Panel Co-organizer and Facilitor

Mostafa Analoui, PhD., (Confirmed)
Senior Director, Pfizer Global Research and Development

Michael Hehenberger, (Confirmed)
Solutions Executive, IBM Global Innovation, Health Care and Life Sciences
                                               
Rainu Kaushal, (Confirmed)
Department of Medicine, Brigham and Women’s Hospital; appointment at Weill-Cornell School of Medicine

 Deepak Ayyagari, PhD
Secretary, Continua Health Alliance,
Principal Scientist, Personal Healthcare Technologies, Sharp

  Q&A
05:15 PM – 05:30 PM Closing Remarks

 
NIST is an agency of the
U.S. Department of Commerce
Privacy statement / security notice / accessibility statement / Disclaimer / FOIA
Date created: June 28, 2007  |  Last updated: September 28, 2007

For additional information, e-mail ITL